Key facts
- This page summarizes Jesse G. Singh's Form 4 filing for James Hardie Industries plc (JHX).
- 9 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 25 Aug 2026, 16:10.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Sale
Sale
Options Exercise
Sale
Sale
Options Exercise
Sale
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Options Exercise
Options Exercise
Additional SEC filing notes
Footnote F1
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.09 to $30.33 inclusive. The reporting person undertakes to provide full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to the extent required by law.
Footnote F2
Represents ordinary shares held by The Jesse Singh 2024 Trust, for which the Reporting Person serves as grantor-trustee
Footnote F3
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.22 to $30.43 inclusive. The reporting person undertakes to provide full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to the extent required by law.
Footnote F4
Represents ordinary shares held by the Jesse Singh 2016 Irrevocable Trust, for which the Reporting Person's spouse serves as trustee
Footnote F5
Represents shares sold through a broker-assisted cashless exercise.
Footnote F6
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.86 to $30.45 inclusive. The reporting person undertakes to provide full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to the extent required by law.
Footnote F7
The options were exercisable as of July 1, 2025, when they were assumed by the issuer in connection with its acquisition of The AZEK Company Inc.